
Chiesi Group
@chiesigroup
International pharmaceutical Group certified B Corp.
ID: 1363886367613280258
https://www.chiesi.com/ 22-02-2021 16:21:02
379 Tweet
2,2K Takipçi
263 Takip Edilen

Everyone has a story to tell, and each story is worth being shared and heard. That’s why we unveiled the #ItsRareForMe project to share the stories of people with rare disease, through something that it’s special and rare to them. Join Chiesi Global Rare Diseases at itsrareforme.com




#ChiesiGroup and Gossamer Bio have entered a global collaboration and license agreement. Combining Chiesi’s respiratory leadership with Gossamer Bio's expertise in pulmonary hypertension, we're contributing to shape the future of healthcare. Discover more: chiesi.com/en/gossamer-bi…


We are proud to announce #ChiesiGroup alliance with Karolinska Institutet to advance medical science and improving patient care through joint research, development, and innovation efforts. 👉 Read more on: chiesi.com/en/alliance-ka…



Siamo orgogliosi di annunciare che Alessandro Chiesi, Presidente del nostro Gruppo è stato eletto tra i cinque Vicepresidenti di Hansen Worldwide per il biennio 2024-2026. Alberto Chiesi, invece, è stato nominato Presidente Onorario per la prima volta nella storia dell’Associazione


🚀 We are thrilled to announce the top ten finalists for the first edition of EIT Health InnoStars Connect 2024, in collaboration with Chiesi Group and #SYNLAB Italia! Find out more at bit.ly/3Auq3Kx





The countdown Begins: Our Biotech Center of Excellence in Parma is almost ready! This cutting-edge facility is set to redefine biotech innovation in Italy and Europe. 👉 Watch our teaser for a sneak peek! #EBW2024 #BiotechWeek #ChiesiGroup #ChiesiThePlaceToBe Assobiotec Federchimica


✨Chiesi Group’s new Biotech Center of Excellence brings the future of #medicine to Parma! ✨ This cutting-edge facility will house the entire supply chain under one roof, streamlining development, boosting #innovation, and accelerating new treatments. bit.ly/4dnqbJR

🌍 #Competitividad | El nuevo Centro Biotech busca fortalecer la producción biofarmacéutica en Europa, alineándose con el informe de Mario Draghi sobre innovación Chiesi Group #Biotecnología i.mtr.cool/yvgjtjczma

Chiesi Group investing 400 million euros in new biotech center thepharmaletter.com/c-hiesi-invest…
